AI Summary

A recent analysis shows that U.S. hospitals have markedly increased the use of prostate magnetic‑resonance imaging before performing biopsies. Multiple randomized trials have demonstrated that pre‑biopsy MRI can better target suspicious lesions and detect aggressive cancers, prompting progressively stronger guideline recommendations for its use. The new data reveal that this evidence is translating into practice, with a sharp rise in MRI‑first approaches across the country. No further outcomes or impacts were reported.

AI summaries can be wrong sometimes—always verify important details using the source article.